The role of erythropoietin to prevent red blood cell transfusion in a 2018-2020 two-center cohort of preterm infants
DISCUSSION: No benefit of rHu-EPO in preventing pRBCT was observed in our cohort. The place of rHu-EPO in future requires careful consideration of the population concerned, adjustment of the therapeutic schedule and evolution of the indications for pRBCT.PMID:38315537 | DOI:10.2450/BloodTransfus.641
Source: Blood Transfusion - Category: Hematology Authors: No émie Bailly Roselyne Brat Geraldine Favrais Source Type: research
More News: Blood Transusion | France Health | Hematology | Iron | Perinatology & Neonatology | Study